ijms-logo

Journal Browser

Journal Browser

The Road to Tolerance: Mechanism of Immune Homeostasis in Health and Disease

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: 20 September 2024 | Viewed by 688

Special Issue Editor


E-Mail Website
Guest Editor
1. Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Taoyuan, Taiwan
2. Liver Transplantation Center, Kaohsiung Chang Gung Memotial Hospital, Kaohsiung, Taiwan
Interests: transplant immunology; liver biology; biomarker discovery; photobiomodulation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Our immune system has a unique mechanism for immune homeostasis and its activation or suppression would be depending on pathophysiological conditions. For the protection from invading microorganisms, innate and adaptive immunity should be activated for the clearance of microorganisms. Alternatively, our immune system should be tolerance to nonharmful antigens/pathogens such as autoantigens, food antigens and commensal bacteria. For the inhibition of tumor cell growth and metastasis, our immune system surveys abnormal cell development (i.e., immune surveillance), while aggressive tumor cells would induce immunosuppressive tumor microenvironment for tumor immune escape. On the other hand, the induction of graft acceptance (tolerance) is an ultimate goal in transplant immunology. The scope of the Special Issue is to summarize the current understanding of immune regulatory mechanisms for immune homeostasis in various research models such as infection, autoimmunity, tumor immunity, transplant immunity and fetomaternal tolerance.

Topics include, but are not limited to:

  • Molecular mechanisms of self and non-self recognition;
  • Molecular mechanisms of immune activation and tolerance induction;
  • Molecular mechanisms of disease progression and its suppression;
  • Biomarker discovery for prediction of immune status in health and disease;
  • The development of therapeutic strategies for immune modulation.

Dr. Toshiaki Nakano
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 1722 KiB  
Article
Soluble Neuropilin-1 Is Elevated in Sepsis and Correlates with Organ Dysfunction and Long-Term Mortality in Critical Illness
by Philipp Hohlstein, Eileen Schumacher, Samira Abu Jhaisha, Jule K. Adams, Maike R. Pollmanns, Carolin V. Schneider, Karim Hamesch, Katarina Horvathova, Theresa H. Wirtz, Frank Tacke, Christian Trautwein, Ralf Weiskirchen and Alexander Koch
Int. J. Mol. Sci. 2024, 25(10), 5438; https://doi.org/10.3390/ijms25105438 - 16 May 2024
Viewed by 179
Abstract
Critical illness and sepsis may cause organ failure and are recognized as mortality drivers in hospitalized patients. Neuropilin-1 (NRP-1) is a multifaceted transmembrane protein involved in the primary immune response and is expressed in immune cells such as T and dendritic cells. The [...] Read more.
Critical illness and sepsis may cause organ failure and are recognized as mortality drivers in hospitalized patients. Neuropilin-1 (NRP-1) is a multifaceted transmembrane protein involved in the primary immune response and is expressed in immune cells such as T and dendritic cells. The soluble form of NRP-1 (sNRP-1) acts as an antagonist to NRP-1 by scavenging its ligands. The aim of this study was to determine the value of sNRP-1 as a biomarker in critical illness and sepsis. We enrolled 180 critically ill patients admitted to a medical intensive care unit and measured serum sNRP-1 concentrations at admission, comparing them to 48 healthy individuals. Critically ill and septic patients showed higher levels of sNRP-1 compared to healthy controls (median of 2.47 vs. 1.70 nmol/L, p < 0.001). Moreover, sNRP-1 was also elevated in patients with sepsis compared to other critical illness (2.60 vs. 2.13 nmol/L, p = 0.01), irrespective of disease severity or organ failure. In critically ill patients, sNRP-1 is positively correlated with markers of kidney and hepatic dysfunction. Most notably, critically ill patients not surviving in the long term (one year after admission) showed higher concentrations of sNRP-1 at the time of ICU admission (p = 0.036), with this association being dependent on the presence of organ failure. Critically ill and septic patients exhibit higher serum concentrations of circulating sNRP-1, which correlates to organ failure, particularly hepatic and kidney dysfunction. Full article
Show Figures

Figure 1

Back to TopTop